CA2220038A1 - Dispositif pour la livraison de forte dose de substance pharmaceutique, nutraceutique, agricole, biologique et chimique - Google Patents

Dispositif pour la livraison de forte dose de substance pharmaceutique, nutraceutique, agricole, biologique et chimique Download PDF

Info

Publication number
CA2220038A1
CA2220038A1 CA 2220038 CA2220038A CA2220038A1 CA 2220038 A1 CA2220038 A1 CA 2220038A1 CA 2220038 CA2220038 CA 2220038 CA 2220038 A CA2220038 A CA 2220038A CA 2220038 A1 CA2220038 A1 CA 2220038A1
Authority
CA
Canada
Prior art keywords
delivery device
ethylcellulose
tablets
water soluble
dialyzing membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA 2220038
Other languages
English (en)
Inventor
Amina Odidi
Isa Odidi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CA 2220038 priority Critical patent/CA2220038A1/fr
Publication of CA2220038A1 publication Critical patent/CA2220038A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N25/00—Biocides, pest repellants or attractants, or plant growth regulators, characterised by their forms, or by their non-active ingredients or by their methods of application, e.g. seed treatment or sequential application; Substances for reducing the noxious effect of the active ingredients to organisms other than pests
    • A01N25/34—Shaped forms, e.g. sheets, not provided for in any other sub-group of this main group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pest Control & Pesticides (AREA)
  • Agronomy & Crop Science (AREA)
  • Plant Pathology (AREA)
  • Toxicology (AREA)
  • Dentistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Environmental Sciences (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
CA 2220038 1998-01-05 1998-01-05 Dispositif pour la livraison de forte dose de substance pharmaceutique, nutraceutique, agricole, biologique et chimique Abandoned CA2220038A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA 2220038 CA2220038A1 (fr) 1998-01-05 1998-01-05 Dispositif pour la livraison de forte dose de substance pharmaceutique, nutraceutique, agricole, biologique et chimique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA 2220038 CA2220038A1 (fr) 1998-01-05 1998-01-05 Dispositif pour la livraison de forte dose de substance pharmaceutique, nutraceutique, agricole, biologique et chimique

Publications (1)

Publication Number Publication Date
CA2220038A1 true CA2220038A1 (fr) 1999-07-05

Family

ID=29275151

Family Applications (1)

Application Number Title Priority Date Filing Date
CA 2220038 Abandoned CA2220038A1 (fr) 1998-01-05 1998-01-05 Dispositif pour la livraison de forte dose de substance pharmaceutique, nutraceutique, agricole, biologique et chimique

Country Status (1)

Country Link
CA (1) CA2220038A1 (fr)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US7731989B2 (en) 2001-10-25 2010-06-08 Depomed, Inc. Gastric retained gabapentin dosage form
US7736667B2 (en) * 2000-02-04 2010-06-15 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US8580302B2 (en) 2000-11-20 2013-11-12 Warner Chilcott Company, Llc Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8592481B2 (en) 2005-12-29 2013-11-26 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8329215B2 (en) 2000-02-04 2012-12-11 Depomed, Inc. Shell and core dosage form approaching zero-order drug release
US9597338B2 (en) 2000-02-04 2017-03-21 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US7736667B2 (en) * 2000-02-04 2010-06-15 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US8043630B2 (en) 2000-02-04 2011-10-25 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US8945619B2 (en) 2000-02-04 2015-02-03 Depomed, Inc. Shell-and-core dosage form approaching zero-order drug release
US9089492B2 (en) 2000-11-20 2015-07-28 Warner Chilcott Company, Llc Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8580302B2 (en) 2000-11-20 2013-11-12 Warner Chilcott Company, Llc Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures
US8333992B2 (en) 2001-10-25 2012-12-18 Depomed, Inc. Gastric retained gabapentin dosage form
US8529955B2 (en) 2001-10-25 2013-09-10 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US8333991B2 (en) 2001-10-25 2012-12-18 Depomed, Inc. Gastric retained gabapentin dosage form
US7612112B2 (en) 2001-10-25 2009-11-03 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US8409613B2 (en) 2001-10-25 2013-04-02 Depomed, Inc. Gastric retained gabapentin dosage form
US8440232B2 (en) 2001-10-25 2013-05-14 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US8475813B2 (en) 2001-10-25 2013-07-02 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US8252332B2 (en) 2001-10-25 2012-08-28 Depomed Inc Gastric retained gabapentin dosage form
US8580303B2 (en) 2001-10-25 2013-11-12 Depomed, Inc. Gastric retained gabapentin dosage form
US8231905B2 (en) 2001-10-25 2012-07-31 Depomed, Inc. Gastric retained gabapentin dosage form
US7731989B2 (en) 2001-10-25 2010-06-08 Depomed, Inc. Gastric retained gabapentin dosage form
US8802157B2 (en) 2001-10-25 2014-08-12 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage form
US8192756B2 (en) 2001-10-25 2012-06-05 Depomed, Inc. Gastric retained gabapentin dosage form
US8119166B2 (en) 2001-10-25 2012-02-21 Depomed, Inc. Methods of treatment using a gastric retained gabapentin dosage
US8592481B2 (en) 2005-12-29 2013-11-26 Depomed, Inc. Gastric retentive gabapentin dosage forms and methods for using same

Similar Documents

Publication Publication Date Title
US6479075B1 (en) Pharmaceutical formulations for acid labile substances
US6893661B1 (en) Controlled release formulations using intelligent polymers
EP2555756B1 (fr) Compositions pharmaceutiques à libération contrôlée de tapentadol
CN1407884B (zh) 控释氢可酮制剂
RU2376983C2 (ru) Гастроретентивные композиции и способ их изготовления
US6224909B1 (en) Fast decomposing pellets
DK174992B1 (da) Farmaceutisk præparat med langsom frigivelse samt anvendelse af visse additiver i sådanne til opnåelse af langsom frigivelse
RU2375048C2 (ru) Фармацевтическая композиция с набухающим покрытием
KR19990028693A (ko) 불용성 약물의 방출 조정 배합물
SK282854B6 (sk) Dávkovacia forma s riadeným uvoľňovaním obsahujúca azitromycín
AU2002366029B2 (en) Preparation compositions containing acid-unstable physiologically active compounds and process for producing the same
US9387178B2 (en) Modified release tranexamic acid formulation
US20090148519A1 (en) Pulsed-release preparation having improved disintegration properties in vivo
AU2004259226B2 (en) Pharmaceutical compositions having a swellable coating
US20010001658A1 (en) Granule modulating hydrogel system
WO2007075980A2 (fr) Comprimes de lansoprazole se desintegrant oralement
US20030091634A1 (en) Delayed release tablet of venlafaxin
CA2220038A1 (fr) Dispositif pour la livraison de forte dose de substance pharmaceutique, nutraceutique, agricole, biologique et chimique
US20030059466A1 (en) Delayed release tablet of venlafaxin
US20050163846A1 (en) Preparation composition containing acid-unstable physiologically active compound, and process for producing same
MXPA05004648A (es) Comprimidos orales de liberacion extendida y procedimientos de preparacion y uso de los mismos.
WO2005051348A2 (fr) Comprimes de pantoprazole a enrobage enterique
JPH0130A (ja) 徐放性製剤
US20040228918A1 (en) Granule modulating hydrogel system
WO2011086568A1 (fr) Composition à libération contrôlée pour la lamotrigine

Legal Events

Date Code Title Description
FZDE Dead